O:2-CRM197 Conjugates against Salmonella Paratyphi A

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Micoli, Francesca ^a   Rondini, Simona ^a   Gavini, Massimiliano ^a   Lanzilao, Luisa ^a   Medaglini, Donata ^b   Saul, Allan ^a   Martin, Laura B ^a  

^a NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEOXY MANNO OCTULOSONIC ACID; ANTIINFECTIVE AGENT; BACTERIAL POLYSACCHARIDE; DIPHTHERIA TOXOID CRM197; O SPECIFIC POLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; BIOCHEMISTRY; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG SYNTHESIS; FEMALE; IMMUNOGENICITY; MOUSE; NONHUMAN; PARATYPHOID FEVER; SALMONELLA PARATYPHI;

ANIMALS; BACTERIAL PROTEINS; CARBOHYDRATE SEQUENCE; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; O ANTIGENS; PARATYPHOID FEVER; SALMONELLA PARATYPHI A; TYPHOID-PARATYPHOID VACCINES; VACCINES, CONJUGATE;

MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA PARATYPHI;

EID: 84868672325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0047039     Document Type: Article

References (38)

1. Crump JA, Mintz ED (2010) Global trends in typhoid and paratyphoid Fever. Clin Infect Dis 50: 241-246. 10.1086/649541 [doi].
2. Bodhidatta L, Taylor DN, Thisyakorn U, Echeverria P, (1987) Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Rev Infect Dis 9: 841-845.
3. Dong BQ, Yang J, Wang XY, Gong J, von Seidlein L, et al. (2010) Trends and disease burden of enteric fever in Guangxi province, China, 1994-2004. Bull World Health Organ 88: 689-696. 10.2471/BLT.09.069310 [doi].
4. Sood S, Kapil A, Dash N, Das BK, Goel V, et al. (1999) Paratyphoid fever in India: An emerging problem. Emerg Infect Dis 5: 483-484.
5. Podda A, Saul AJ, Arora R, Bhutta Z, Sinha A, et al. (2010) Conjugate vaccines for enteric fever: proceedings of a meeting organized in New Delhi, India in 2009. J Infect Dev Ctries 4: 404-411.
6. Maskey AP, Basnyat B, Thwaites GE, Campbell JI, Farrar JJ, et al. (2008) Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993-2003. Trans R Soc Trop Med Hyg 102: 91-95. S0035-9203(07)00330-6 [pii];10.1016/j.trstmh.2007.10.003 [doi].
7. Ochiai RL, Wang X, von Seidlein L, Yang J, Bhutta ZA, et al. (2005) Salmonella paratyphi A rates, Asia. Emerg Infect Dis 11: 1764-1766.
8. Abucejo PE, Capeding MR, Lupisan SP, Arcay J, Sombrero LT, et al. (2001) Blood culture confirmed typhoid fever in a provincial hospital in the Philippines. Southeast Asian J Trop Med Public Health 32: 531-536.
9. Vollaard AM, Ali S, Widjaja S, Asten HA, Visser LG, et al. (2005) Identification of typhoid fever and paratyphoid fever cases at presentation in outpatient clinics in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 99: 440-450. S0035-9203(05)00003-9 [pii];10.1016/j.trstmh.2004.09.012 [doi].
10. Khan MI, Sahito SM, Khan MJ, Wassan SM, Shaikh AW, et al. (2006) Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial. Bull World Health Organ 84: 72-77. S0042-96862006000100017 [pii];/S0042-96862006000100017 [doi].
11. Ekdahl K, de Jong B, Andersson Y, (2005) Risk of travel-associated typhoid and paratyphoid fevers in various regions. J Travel Med 12: 197-204.
12. Meltzer E, Sadik C, Schwartz E, (2005) Enteric fever in Israeli travelers: a nationwide study. J Travel Med 12: 275-281.
13. Schwartz E, Shlim DR, Eaton M, Jenks N, Houston R, (1990) The effect of oral and parenteral typhoid vaccination on the rate of infection with Salmonella typhi and Salmonella paratyphi A among foreigners in Nepal. Arch Intern Med 150: 349-351.
14. Fangtham M, Wilde H (2008) Emergence of Salmonella paratyphi A as a major cause of enteric fever: need for early detection, preventive measures, and effective vaccines. J Travel Med 15: 344-350. JTM237 [pii];10.1111/j.1708-8305.2008.00237.x [doi].
15. Kulkarni SV, Narayan A, Indumathi VA, Rao TS, Kempegowda P, (2011) Salmonella Paratyphi A in India- Changing trends in presentation and antibiotic susceptibility. Asian Journal of Medical Sciences 2: 14-17.
16. Wilde H (2007) Enteric fever due to Salmonella typhi and paratyphi A a neglected and emerging problem. Vaccine 25: 5246-5247. S0264-410X(07)00481-1 [pii];10.1016/j.vaccine.2007.04.053 [doi].
17. WHO (2008) Typhoid vaccines: WHO position paper. Wkly Epidemiol Rec 83: 49-59.
18. Roland KL, Tinge SA, Kochi SK, Thomas LJ, Killeen KP (2010) Reactogenicity and immunogenicity of live attenuated Salmonella enterica serovar Paratyphi A enteric fever vaccine candidates. Vaccine 28: 3679-3687. S0264-410X(10)00355-5 [pii];10.1016/j.vaccine.2010.03.019 [doi].
19. Gat O, Galen JE, Tennant S, Simon R, Blackwelder WC, et al. (2011) Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines. PLoS Negl Trop Dis 5: e1373. 10.1371/journal.pntd.0001373 [doi];PNTD-D-11-00736 [pii].
20. Micoli F, Rondini S, Pisoni I, Proietti D, Berti F, et al. (2011) Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi. Vaccine 29: 712-720. S0264-410X(10)01631-2 [pii];10.1016/j.vaccine.2010.11.022 [doi].
21. Rondini S, Micoli F, Lanzilao L, Hale C, Saul AJ, et al. (2011) Evaluation of the Immunogenicity and Biological Activity of the Citrobacter freundii Vi-CRM197 Conjugate as a Vaccine for Salmonella enterica Serovar Typhi. Clin Vaccine Immunol 18: 460-468. CVI.00387-10 [pii];10.1128/CVI.00387-10 [doi].
22. Broker M, Costantino P, DeTora L, McIntosh ED, Rappuoli R (2011) Biochemical and biological characteristics of cross-reacting material 197 (CRM197), a non-toxic mutant of diphtheria toxin: use as a conjugation protein in vaccines and other potential clinical applications. Biologicals 39: 195-204. S1045-1056(11)00065-0 [pii];10.1016/j.biologicals.2011.05.004 [doi].
23. Van DP, Kafeja F, Anemona A, Basile V, Hilbert AK, et al. (2011) Safety, Immunogenicity and Dose Ranging of a New Vi-CRM(197) Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults. PLoS One 6: e25398. 10.1371/journal.pone.0025398 [doi];PONE-D-11-13873 [pii].
24. Konadu E, Shiloach J, Bryla DA, Robbins JB, Szu SC, (1996) Synthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetyls. Infect Immun 64: 2709-2715.
25. Konadu EY, Lin FY, Ho VA, Thuy NT, Van Bay P, et al. (2000) Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun 68: 1529-1534.
26. Whitfield C, Kaniuk N, Frirdich E (2003) Molecular insights into the assembly and diversity of the outer core oligosaccharide in lipopolysaccharides from Escherichia coli and Salmonella. J Endotoxin Res 9: 244-249. 10.1179/096805103225001440 [doi].
27. Hellerqvist CG, Lindberg B, Samuelsson K, Lindberg AA, (1971) Structural studies on the O-specific side-chains of the cell-wall lipopolysaccharide from Salmonella parathyphi A var. durazzo. Acta Chem Scand 25: 955-961.
28. Palmer DW, Peters T Jr, (1969) Automated determination of free amino groups in serum and plasma using 2,4,6-trinitrobenzene sulfonate. Clin Chem 15: 891-901.
29. Dubois M, Gilles KA, Hamilton K, Rebers PA, Smith F (1956) Colorimetric Method for Determination of Sugars and Related Sustances. In: Analytical Chemistry. 350 p.
30. Satake K, Okuyama T, Ohashi M, Shinoda T, (1960) The spectrophotometric determination of amine, amino acid and peptide with 2,4,6-trinitrobenzene 1-sulfonic acid. J Biochem 47: 654.
31. Macgee J, Doudoroff M, (1954) A new phosphorylated intermediate in glucose oxidation. J Biol Chem 210: 617-626.
32. Nohta H, Sonoda J, Yoshida H, Satozono H, Ishida J, et al. (2003) Liquid chromatographic determination of dicarboxylic acids based on intramolecular excimer-forming fluorescence derivatization. J Chromatogr A 1010: 37-44.
33. Miron T, Wilchek M, (1982) A spectrophotometric assay for soluble and immobilized N-hydroxysuccinimide esters. Anal Biochem 126: 433-435.
34. Lane CF (1975) Sodium Cyanoborohydride. A Highly Selective Reducing Agent for Organic Functional Groups. In: Synthesis. 135 p.
35. Taylor DN, Trofa AC, Sadoff J, Chu C, Bryla D, et al. (1993) Synthesis, characterization, and clinical evaluation of conjugate vaccines composed of the O-specific polysaccharides of Shigella dysenteriae type 1, Shigella flexneri type 2a, and Shigella sonnei (Plesiomonas shigelloides) bound to bacterial toxoids. Infect Immun 61: 3678-3687.
36. Costantino P, Rappuoli R, Berti F, (2011) The design of semi-synthetic and synthetic glycoconjugate vaccines. Expert Opinion on Drug Discovery 6: 1045-1066 doi: 10.1517/17460441.2011.609554.
37. Chu CY, Liu BK, Watson D, Szu SS, Bryla D, et al. (1991) Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid. Infect Immun 59: 4450-4458.
38. Watson DC, Robbins JB, Szu SC, (1992) Protection of mice against Salmonella typhimurium with an O-specific polysaccharide-protein conjugate vaccine. Infect Immun 60: 4679-4686.